Real-World Multimodal Day-Care Intervention for Mild Cognitive Impairment with Lewy Bodies: A Prospective 3-Year

Miyuki Nemoto1, Kiyotaka Nemoto2, Miho Ota1

  • 1Department of Psychiatry, Division of Clinical Medicine, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.

Abstract

Insights

Individuals with mild cognitive impairment with Lewy bodies (MCI-LB) showed similar cognitive changes to those with mild cognitive impairment due to Alzheimer's disease (MCI-AD) when participating in a multimodal program. This suggests non-pharmacological interventions may benefit both MCI subtypes.

Area of Science:

  • Neurology
  • Gerontology
  • Cognitive Science

Background:

  • Mild cognitive impairment with Lewy bodies (MCI-LB) typically presents with faster cognitive decline than mild cognitive impairment due to Alzheimer's disease (MCI-AD).
  • Limited data exists on the long-term cognitive trajectories of MCI-LB patients in structured non-pharmacological multimodal programs.
  • Understanding these trajectories is crucial for developing effective interventions.

Purpose of the Study:

  • To preliminarily examine and compare cognitive changes over time in individuals with MCI-LB and MCI-AD.
  • To assess the impact of a structured multimodal intervention on cognitive trajectories in these patient groups.
  • To provide initial insights into potential differences or similarities in response to non-pharmacological treatments.

Main Methods:

  • A prospective study was conducted at University of Tsukuba Hospital (April 2013-February 2020).
  • 74 participants (14 MCI-LB, 60 MCI-AD) enrolled in the Cognitive Improvement Day-Care (CIDC) program, a multimodal intervention including physical exercise, cognitive training, music, and art therapy.
  • Annual cognitive assessments using the Japanese version of the Mini-Mental State Examination (MMSE-J) were performed for up to 3 years, analyzed with linear mixed-effects models.

Main Results:

  • The overall annual cognitive decline was -0.36 points/year.
  • MCI-LB group showed an annual decline of -0.44 points/year, while the MCI-AD group declined at -0.34 points/year.
  • No significant group-by-time interaction was observed over the 3-year follow-up (p=0.97), indicating comparable cognitive trajectories between groups.

Conclusions:

  • Individuals with MCI-LB demonstrated longitudinal cognitive trajectories comparable to MCI-AD patients within a structured multimodal intervention, as measured by the MMSE-J.
  • These findings suggest that multimodal non-pharmacological programs may yield similar cognitive outcomes for both MCI subtypes.
  • Further research with larger cohorts and more detailed cognitive assessments is warranted to confirm these results and explore subtype-specific responses.

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Specialized Care Centers and Settings-II01:30

Specialized Care Centers and Settings-II

Rural Health Centers
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
1.3K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K
Cognitive Therapy01:25

Cognitive Therapy

Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
1.4K